Advanced Oncotherapy PLC Stock price London S.E.
Equities
GB00B16JQ761
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | 0.00% |
Feb. 29 | EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding | AN |
Feb. 02 | Advanced Oncotherapy eyes USD15 million tranche in February | AN |
Financials (USD)
Sales 2020 | - | Sales 2021 | - | Capitalization | 172M |
---|---|---|---|---|---|
Net income 2020 | -25M | Net income 2021 | -29M | EV / Sales 2020 | - |
Net Debt 2020 | 48.32M | Net Debt 2021 | 49.09M | EV / Sales 2021 | - |
P/E ratio 2020 |
-4.11
x | P/E ratio 2021 |
-4.93
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 52.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 14-08-26 | |
Director of Finance/CFO | - | 16-09-30 | |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Jo Cross
BRD | Director/Board Member | 64 | 20-09-28 |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Hans von Celsing
BRD | Director/Board Member | 74 | 17-01-25 |
1st Jan change | Capi. | |
---|---|---|
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |
- Stock
- Equities
- Stock Advanced Oncotherapy plc
- Stock Advanced Oncotherapy PLC - London S.E.